|
KIAA0831 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.662900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.412120E-02 |
| Normal-vs-Stage2 |
1.915820E-01 |
| Normal-vs-Stage3 |
6.023600E-01 |
| Normal-vs-Stage4 |
3.871800E-01 |
| Stage1-vs-Stage2 |
9.242400E-01 |
| Stage1-vs-Stage3 |
3.008800E-01 |
| Stage1-vs-Stage4 |
6.535000E-01 |
| Stage2-vs-Stage3 |
5.107200E-01 |
| Stage2-vs-Stage4 |
7.274200E-01 |
| Stage3-vs-Stage4 |
8.318000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.038900E-03 |
| Normal-vs-AfricanAmerican |
3.641600E-02 |
| Normal-vs-Asian |
7.185400E-01 |
| Caucasian-vs-AfricanAmerican |
8.684000E-01 |
| Caucasian-vs-Asian |
2.870400E-01 |
| AfricanAmerican-vs-Asian |
2.975200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.204900E-03 |
| Normal-vs-Female |
5.595900E-02 |
| Male-vs-Female |
6.193000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.535400E-01 |
| Normal-vs-Extreme_Weight |
7.602300E-02 |
| Normal-vs-Obese |
3.583800E-03 |
| Normal-vs-Extreme_Obese |
2.910400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.434000E-01 |
| Normal_Weight-vs-Obese |
5.979700E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.129200E-01 |
| Extreme_Weight-vs-Obese |
1.653970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.390600E-01 |
| Obese-vs-Extreme_Obese |
4.493200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.842800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.984190E-04 |
| Normal-vs-Age(61-80Yrs) |
1.539570E-01 |
| Normal-vs-Age(81-100Yrs) |
7.152400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.062200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.543600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.898330E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.083600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.625700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.286800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62540999999461E-05 |
| Normal-VS-Type2 PRCC |
1.269020E-01 |
| Normal-VS-KIRP CIMP |
1.595960E-01 |
| Normal-VS-Unclassified PRCC |
4.267800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.28173077391148E-12 |
| Type1 PRCC-VS-KIRP CIMP |
9.965600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.401400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.522000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.917600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.627600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.698800E-01 |
| Normal-vs-N1 |
4.935600E-02 |
| Normal-vs-N2 |
1.757570E-01 |
| N0-vs-N1 |
3.977800E-02 |
| N0-vs-N2 |
2.882600E-01 |
| N1-vs-N2 |
1.140000E-01 |
|
|
